Pathology laboratory screened New York state’s first potential donor—a COVID-19 survivor for antibodies that can be used to treat or vaccine against COVID-19.
A team led by Pathology researcher, Alex Chavez, MD, PhD, will use a new drug screening approach to rapidly screen a large number of compounds that block the protease of 2019-nCoV.
In this study, the authors reported on a single-institution experience on 3-year prospective PSCPC regarding risk of malignancy (ROM) and the overall risk of malignancy (OROM).
Dr. Danielle Pendrick will be presenting a poster highlight the IDGCP as a new healthcare delivery framework with a strong emphasis in clinical and laboratory collaboration.
The official launch of the WIRhE took place on Saturday, September 28, in Florence, Italy, on the occasion of the Second Annual International Symposium for the Eradication of Rh disease.
